CAK Tri-Axis Dominant-Primary Series III-NP

Mentha × piperita

Peppermint

Tier IIICAK Tri-Axis Dominant-Primary Series

Target Trait

1.95×

fold-change

Cooling-dominant tri-axis A+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-02140

Genomic Edits

GC Content

45.1%

Construct Length

5,871 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

TRPM8 + Polyphenol-astringency axis + CaSR

IFI Score

195

Pathway Edits

TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent CAK pathway operation
Cross-pathway regulatory circuit for cooling-dominant CAK triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, Polyphenol-astringency axis, and CaSR pathways simultaneously engineeredCooling-dominant tri-axis expression strategy (CAK) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier III CAK triple-axis construct for advanced multi-modal sensory architecture combining cooling, astringency, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$1749 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities